Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis with 3 years of treatment: results from a long-term study
Rheumatology (Oxford). 2021;60(5):2256-2266.
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Rheumatology (Oxford). 2021;60(5):2256-2266.
Wells AF, et al. Rheumatol Ther. 2021. Epub ahead of print. DOI: 10.1007/s40744-021-00317-9.
Mod Rheumatol 2021;26:1–16.
Ann Rheum Dis 2021;80:96–102.
Rheumatology 2020; doi:10.1093/rheumatology/keaa576
N Engl J Med 2020;383:1511–21 DOI: 10.1056/NEJMoa2008250
Clin Exp Rheumatol . Jul-Aug 2020;38(4):732-741. Epub 2020 May 20.
Intern Med. 2020;59(6):817-821
Ann Rheum Dis. 2020 Jan 22. pii: annrheumdis-2019-216655.